Global /Japan /Healthcare /Medical Distribution /8129
chevron_leftBack
Toho Holdings Co., Ltd. logo

Toho Holdings Co., Ltd.

8129
TSE: 8129 Delayed
4,474JPY 2.5%
27.96 USD
As of 5 June 2026, Toho Holdings Co., Ltd. has a market cap of $1.77B USD, ranking #7659 globally and #536 in Japan. It ranks #634 in the Healthcare sector, and #17 in the Medical Distribution industry.
Global Rank
7659
Country Rank
536
Sector Rank
634
Industry Rank
17
Key Stats
Market Cap
$1.77BUSD
282.49B JPY
Enterprise Value
$1.0BUSD
160.56B JPY
Revenue (TTM)
$9.62BUSD
1.54T JPY
EBITDA (TTM)
$145.85MUSD
23.34B JPY
Net Income (TTM)
$150.22MUSD
24.04B JPY
EBITDA Margin
1.5%
Profit Margin
1.6%
PE Ratio
12.2
Forward PE
19.7
PS Ratio
0.2
PB Ratio
1.1
EV/EBITDA
6.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Distribution
CEO
Hiromi Edahiro open_in_new
Employees
7,609
Founded
1948
Website
tohohd.co.jp open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
2.5% 6.2% -4% -2.4% -8.6% 0.6%

News

Loading...

Markets

Exchange Ticker Price
Tokyo Stock Exchange
MIC: XTKS
PRIMARY
8129
東邦ホールディングス株式会社
ISIN: JP3602600003
Shares Out.:
64.702M1 Shares Float: 44.114M2
TV:
SA:
YF:
GF:
BA:
MS:
4,474 JPY
Frankfurt Stock Exchange
MIC: XFRA
TON
東邦ホールディングス株式会社
ISIN: JP3602600003
TV:
SA:
YF:
GF:
BA:
TON
MS:
23.20 EUR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Toho Holdings Co., Ltd.

Toho Holdings Co., Ltd. engages in the wholesale distribution of pharmaceutical products in Japan. It operates in four segments: Pharmaceutical Wholesale Business, Dispensing Pharmacy Business, Pharmaceutical Manufacturing and Sales Business, and Other Peripheral Businesses. The company sells pharmaceuticals, narcotics, reagents, and medical devices to hospitals, clinics, and dispensing pharmacies. It is also involved in the management of the dispensing pharmacies business; operates health insurance pharmacy; provision of support home medical care services; peripheral businesses; core system operations; and real estate agency business. In addition, the company manufacture and sell pharmaceuticals; sells generic drugs; and manufactures injection drugs on consignment. Further, it provides support services, including the development and sale of customer support systems, assistance in the start-up of medical institutions and pharmacies, management consulting services, medical support, and personnel recruitment. Additionally, the company offers various customer support systems, including ENIF, an information terminal for pharmaceutical ordering; ENI-Pharmacy, a support system for the separation of dispensing and prescribing functions; LXMATE Helios a medical care appointment system; KAITOS, an online medical consultation and medication guidance system; ENIFwin Nex-Sus, an inventory control system for large hospitals ENIFvoice SP/ ENIFvoice SP + A/ ENIFvoice Core, a supporting system for electronic medication history recording with voice recognition. The company was incorporated in 1948 and is headquartered in Chuo, Japan.

Similar Companies

Industry: Medical Distribution (Japan)
Name
Market Cap diff.
PE
$3.61B
577.66B JPY
104%
14.1
$2.71B
434.49B JPY
54%
12.9
9987
$2.35B
376.13B JPY
33%
11.3
8283
$1.77B
283.73B JPY
0.4%
13.1
8086
$1.56B
250.11B JPY
-11%
18.6
$1.35B
216.61B JPY
-23%
15.7
Industry: Medical Distribution (Global)
Name
Market Cap diff.
PE
MCK
$100.76B
6K%
24.0
COR
$60.58B
3K%
37.4
$47.73B
3K%
29.6
HSIC
$8.47B
380%
22.6
$7.48B
58.61B HKD
324%
7.2
GALE
$5.3B
4.2B CHF
200%
23.0
chevron_leftBack